Novo CEO gives key update on when its next obesity drug could launch

Mike Doustdar said Novo is "already in production mode" for CagriSema.

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.